These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
274 related items for PubMed ID: 16870257
41. Anti-C1q, anti-chromatin/nucleosome, and anti-dsDNA antibodies in juvenile systemic lupus erythematosus patients. Jesus AA, Campos LM, Liphaus BL, Carneiro-Sampaio M, Mangueira CL, Rosseto EA, Silva CA, Scheinberg M. Rev Bras Reumatol; 2012 Dec; 52(6):976-81. PubMed ID: 23223707 [Abstract] [Full Text] [Related]
42. Do circulating antibodies against C1q reflect the activity of lupus nephritis? Smykał-Jankowiak K, Niemir ZI, Polcyn-Adamczak M. Pol Arch Med Wewn; 2011 Sep; 121(9):287-95. PubMed ID: 21860370 [Abstract] [Full Text] [Related]
43. Detection of autoantibodies against the globular domain of human C1q in the sera of systemic lupus erythematosus patients. Tsacheva I, Radanova M, Todorova N, Argirova T, Kishore U. Mol Immunol; 2007 Mar; 44(8):2147-51. PubMed ID: 17049989 [Abstract] [Full Text] [Related]
44. [Is autoantibody determination in patients with systemic lupus erythematosus useful? Anti-C1q-autoantibody as an example]. Trendelenburg M, Schifferli JA. Praxis (Bern 1994); 1998 Dec 24; 87(51-52):1811-3. PubMed ID: 10025155 [Abstract] [Full Text] [Related]
45. Role of anti-C1q autoantibodies in the pathogenesis of lupus nephritis. Trouw LA, Daha MR. Expert Opin Biol Ther; 2005 Feb 24; 5(2):243-51. PubMed ID: 15757386 [Abstract] [Full Text] [Related]
46. Detection of anti-C1q antibodies and anti-C1q globular head domain antibodies in sera from Chinese patients with lupus nephritis. Tan Y, Zhou W, Yu F, Fang Q, Yang HZ, Zhao MH. Mol Immunol; 2009 Jul 24; 46(11-12):2178-82. PubMed ID: 19481805 [Abstract] [Full Text] [Related]
47. Autoantibodies against complement C1q in acute post-streptococcal glomerulonephritis. Kozyro I, Korosteleva L, Chernoshej D, Danner D, Sukalo A, Trendelenburg M. Clin Immunol; 2008 Sep 24; 128(3):409-14. PubMed ID: 18544473 [Abstract] [Full Text] [Related]
48. Infiltrating dendritic cells contribute to local synthesis of C1q in murine and human lupus nephritis. Castellano G, Trouw LA, Fiore N, Daha MR, Schena FP, van Kooten C. Mol Immunol; 2010 Jul 24; 47(11-12):2129-37. PubMed ID: 20417969 [Abstract] [Full Text] [Related]
49. Antibodies against C1q in patients with systemic lupus erythematosus. Trendelenburg M. Springer Semin Immunopathol; 2005 Nov 24; 27(3):276-85. PubMed ID: 16189648 [Abstract] [Full Text] [Related]
50. Clearance of dying cells and systemic lupus erythematosus: the role of C1q and the complement system. Mevorach D. Apoptosis; 2010 Sep 24; 15(9):1114-23. PubMed ID: 20683667 [Abstract] [Full Text] [Related]
51. Anti-C1q Autoantibodies from Systemic Lupus Erythematosus Patients Induce a Proinflammatory Phenotype in Macrophages. Thanei S, Trendelenburg M. J Immunol; 2016 Mar 01; 196(5):2063-74. PubMed ID: 26829984 [Abstract] [Full Text] [Related]
52. Anti-C1q autoantibodies as markers of renal involvement in childhood-onset systemic lupus erythematosus. Picard C, Lega JC, Ranchin B, Cochat P, Cabrera N, Fabien N, Belot A. Pediatr Nephrol; 2017 Sep 01; 32(9):1537-1545. PubMed ID: 28343355 [Abstract] [Full Text] [Related]
53. Autoantibodies in lupus nephritis patients requiring renal transplantation. Stinton LM, Barr SG, Tibbles LA, Yilmaz S, Sar A, Benedikttson H, Fritzler MJ. Lupus; 2007 Sep 01; 16(6):394-400. PubMed ID: 17664229 [Abstract] [Full Text] [Related]
54. Association between ongoing anti-C1q antibody production in peripheral blood and proliferative nephritis in patients with active systemic lupus erythematosus. Gunnarsson I, Rönnelid J, Huang YH, Rogberg S, Nilsson B, Lundberg I, Klareskog L. Br J Rheumatol; 1997 Jan 01; 36(1):32-7. PubMed ID: 9117171 [Abstract] [Full Text] [Related]
55. C1q rs292001 polymorphism and C1q antibodies in juvenile lupus and their relation to lupus nephritis. Mosaad YM, Hammad A, Fawzy Z, El-Refaaey A, Tawhid Z, Hammad EM, Youssef LF, ElAttar EA, Radwan DF, Fawzy IM. Clin Exp Immunol; 2015 Oct 01; 182(1):23-34. PubMed ID: 26095468 [Abstract] [Full Text] [Related]
56. Clinical and pathologic considerations of the qualitative and quantitative aspects of lupus nephritogenic autoantibodies: A comprehensive review. Gatto M, Iaccarino L, Ghirardello A, Punzi L, Doria A. J Autoimmun; 2016 May 01; 69():1-11. PubMed ID: 26879422 [Abstract] [Full Text] [Related]
57. Interference of antimodified C-reactive protein autoantibodies from lupus nephritis in the biofunctions of modified C-reactive protein. Yang XW, Tan Y, Yu F, Zhao MH. Hum Immunol; 2012 Feb 01; 73(2):156-63. PubMed ID: 22192784 [Abstract] [Full Text] [Related]
58. Anti-C1q antibodies: a biomarker for diagnosis and management of lupus nephritis. A narrative review. Calatroni M, Moroni G, Conte E, Stella M, Reggiani F, Ponticelli C. Front Immunol; 2024 Feb 01; 15():1410032. PubMed ID: 38938561 [Abstract] [Full Text] [Related]
59. Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective study. Bruschi M, Moroni G, Sinico RA, Franceschini F, Fredi M, Vaglio A, Cavagna L, Petretto A, Pratesi F, Migliorini P, Locatelli F, Pazzola G, Pesce G, Bagnasco M, Manfredi A, Ramirez GA, Esposito P, Murdaca G, Negrini S, Cipriani L, Trezzi B, Emmi G, Cavazzana I, Binda V, d'Alessandro M, Fenaroli P, Pisani I, Garibotto G, Montecucco C, Santoro D, Scolari F, Volpi S, Mosca M, Tincani A, Candiano G, Prunotto M, Verrina E, Angeletti A, Ravelli A, Ghiggeri GM. Rheumatology (Oxford); 2021 Jul 01; 60(7):3388-3397. PubMed ID: 33351137 [Abstract] [Full Text] [Related]
60. Pathogenic implications for autoantibodies against C-reactive protein and other acute phase proteins. Sjöwall C, Wetterö J. Clin Chim Acta; 2007 Mar 01; 378(1-2):13-23. PubMed ID: 17239838 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]